Home326030 • KRX
add
SK Biopharmaceuticals Co Ltd
Previous close
₩107,900.00
Day range
₩103,200.00 - ₩108,200.00
Year range
₩72,600.00 - ₩119,500.00
Market cap
8.10T KRW
Avg Volume
444.03K
P/E ratio
239.60
Dividend yield
-
Market news
Financials
Income Statement
Revenue
Net income
| (KRW) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | 134.00B | 73.99% |
Operating expense | 99.20B | 14.59% |
Net income | 28.14B | 220.54% |
Net profit margin | 21.00 | 169.28% |
Earnings per share | — | — |
EBITDA | 30.37B | 296.77% |
Effective tax rate | -3.20% | — |
Balance Sheet
Total assets
Total liabilities
| (KRW) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 286.45B | 28.52% |
Total assets | 824.08B | 30.57% |
Total liabilities | 452.56B | 33.33% |
Total equity | 371.52B | — |
Shares outstanding | 78.31M | — |
Price to book | 24.98 | — |
Return on assets | 8.06% | — |
Return on capital | 11.60% | — |
Cash Flow
Net change in cash
| (KRW) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | 28.14B | 220.54% |
Cash from operations | -6.83B | 75.01% |
Cash from investing | 1.82B | -94.60% |
Cash from financing | -1.06B | 22.08% |
Net change in cash | -4.65B | -262.09% |
Free cash flow | -16.76B | -34.19% |
About
Founded
1993
Website
Employees
241
